NM
TECX

Newtyn Management’s Tectonic Therapeutic TECX Stock Holding History

Newtyn Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-93,241
Closed -$1.43M – 47
2024
Q1 		$1.43M Sell
93,241
-134,607
-59% -$2.13M 0.29% 34
2023
Q4 		$3.72M Buy
227,848
+61,181
+37% +$1.05M 0.73% 28
2023
Q3 		$3.08M Buy
+166,667
New +$2.95M 0.76% 27

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Newtyn Management's TECX Position: Q2 2024 in Review

Newtyn Management sold out of Tectonic Therapeutic (TECX) in Q2 2024, closing a stake of 93,241 shares — an estimated $1.43M sold.

Newtyn Management first reported a position in TECX in Q3 2023 and held it in 3 quarters. The position peaked at $3.72M in Q4 2023. 40 funds tracked by Wall St. Rank hold TECX as of Q2 2024.

  • Newtyn Management reported no remaining Tectonic Therapeutic position as of Q2 2024 after selling out during the quarter.
  • Newtyn Management sold 93,241 Tectonic Therapeutic shares in Q2 2024, an estimated $1.43M.
  • Newtyn Management first reported a position in Tectonic Therapeutic in Q3 2023 and held it in 3 quarters.
  • Newtyn Management's Tectonic Therapeutic position peaked at $3.72M in Q4 2023.
  • 40 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2024.

Based on Newtyn Management's 13F filing for Q2 2024, filed 14 Aug 2024.